Human resources have challenged efforts to scale-up HIV prevention, care and treatment programs in low- and middle-income countries.
HIV/AIDSSee more about HIV/AIDS
- state & global data
- view as grid
- view as list
Following on the heels of The Lancet themed issue on HIV prevention launched at AIDS 2008, The Lancet has commissioned a series on the global HIV epidemic among people who use drugs.
AIDS 2010: Integrating Sexual and Reproductive Health and Rights (SRHR) and HIV: Lessons from the Field
At the International Conference on Population and Development in Cairo in 1994, governments worldwide agreed that sexual and reproductive health and rights include HIV services.
AIDS 2010: Safety and Effectiveness of 1% Tenofovir Vaginal Microbicide Gel in South African Women: Results of the CAPRISA 004 Trial
An update of current state of microbicide development will be provided. Speakers will provide a state of microbicide development update, safety and efficacy data from CAPRISA 004 and implications of the CAPRISA 004 trial results for the microbicide and PrEP field.
We must remain committed to the goal of reaching universal access to HIV prevention, treatment and care, and recognize that, post-2010, the best path forward must be informed by lessons learned from the successes and the failures of the efforts undertaken to date.
AIDS 2010: The Forgotten Epidemics: HIV and HCV in Prisons, Pre-Trial Detention, and other Closed Settings
Rates of HIV and HCV in prisons, pre-trial detention centers and other closed settings are much higher than in the community, and risk behaviours – in particular consensual and non-consensual forms of sexual activity and injecting drug use – are prevalent behind bars.
For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance. Chairs: Debrework Zewdie (Ethiopia)Director, Global HIV/AIDS Program for the World BankHelene Gayle (United States)President and CEO of CARE USANora Volkow (United States)Director of the National Institute on Drug Abuse (NIDA), NIH
The success of highly active antiretroviral therapy, HAART, has been evident for 15 years. Such long-term therapy can have complications though, especially when compounded by co-morbid conditions such as ageing and smoking.
Concerted global action has transformed the HIV and AIDS response into a top health and humanitarian priority.
For more information please see the conference Programme-at-a-Glance. Panel 1: Julio Montaner, CanadaBrigitte Schmied, AustriaVladimir Zhovtyak, UkraineAlexandra (Sasha) Volgina, Russian FederationRachel Arinii Judhistari, IndonesiaYves Souteyrand, FrancePaula Akugizibwe, RwandaSharon Lewin, Australia